《非心脏手术后高敏感性心肌肌钙蛋白升高》

  • 来源专题:心血管疾病防治
  • 编译者: 张燕舞
  • 发布时间:2018-05-22
  • 许多接受非心脏手术的患者,尤其是那些心血管疾病风险增加的患者,发现术后高敏感性心肌肌钙蛋白(hs-cTn)升高。 其中大多数没有心肌梗塞的临床表现。 在一项前瞻性研究中,约2000名心血管风险增加的患者(超过2500例手术)在手术前后测量了hs-cTnT。 无论心肌梗死的临床表现如何,hs-cTnT在手术中有16%发生增加,并且与30天和1年的死亡率增加相关。 我们建议在高心血管风险的患者中进行围手术期hs-cTn检测,以筛查心肌损伤和心电图监测,影像学检查或阿司匹林或他汀类药物治疗的需求。

    BACKGROUND Perioperative myocardial injury (PMI) seems to be a contributor to mortality after noncardiac surgery. Because the vast majority of PMIs are asymptomatic, PMI usually is missed in the absence of systematic screening.

    METHODS We performed a prospective diagnostic study enrolling consecutive patients undergoing noncardiac surgery who had a planned postoperative stay of≥24 hours and were considered at increased cardiovascular risk. All patients received a systematic screening using serial measurements of high-sensitivity cardiac troponin T in clinical routine. PMI was defined as an absolute high-sensitivity cardiac troponin T increase of≥14 ng/L from preoperative to postoperative measurements. Furthermore, mortality was compared among patients with PMI not fulfilling additional criteria (ischemic symptoms, new ECG changes, or imaging evidence of loss of viable myocardium) required for the diagnosis of spontaneous acute myocardial infarction versus those that did.

    RESULTS From 2014 to 2015 we included 2018 consecutive patients undergoing 2546 surgeries. Patients had a median age of 74 years and 42% were women. PMI occurred after 397 of 2546 surgeries (16%; 95% confidence interval, 14%-17%) and was accompanied by typical chest pain in 24 of 397 patients (6%) and any ischemic symptoms in 72 of 397 (18%). Crude 30-day mortality was 8.9% (95% confidence interval [CI], 5.7-12.0) in patients with PMI versus 1.5% (95% CI, 0.9-2.0) in patients without PMI (P<0.001). Multivariable regression analysis showed an adjusted hazard ratio of 2.7 (95% CI, 1.5-4.8) for 30-day mortality. The difference was retained at 1 year with mortality rates of 22.5% (95% CI, 17.6-27.4) versus 9.3% (95% CI, 7.9-10.7). Thirty-day mortality was comparable among patients with PMI not fulfilling any other of the additional criteria required for spontaneous acute myocardial infarction (280/397, 71%) versus those with at least 1 additional criterion (10.4%; 95% CI, 6.7-15.7, versus 8.7%; 95% CI, 4.2-16.7;P=0.684).

    CONCLUSIONS PMI is a common complication after noncardiac surgery and, despite early detection during routine clinical screening, is associated with substantial short- and long-term mortality. Mortality seems comparable in patients with PMI not fulfilling any other of the additional criteria required for spontaneous acute myocardial infarction versus those patients who do.

    CLINICAL TRIAL REGISTRATION URL: https://www.clinicaltrials.gov. Unique identifier: NCT025735

  • 原文来源:http://circ.ahajournals.org/content/early/2017/11/29/CIRCULATIONAHA.117.030114
相关报告
  • 《2019年冠状病毒病患者引发肌钙蛋白升高(COVID-19)的致病机制》

    • 来源专题:实验室生物安全
    • 编译者:张虎
    • 发布时间:2020-05-13
    • 2019年冠状病毒病(COVID-19)是一种大流行性疾病,已经影响到全球180多万人,由于严重疾病的高比例,使医疗系统不堪重负,并导致超过10万人死亡。自从在中国进行第一次数据分析以来,相当一部分患者发现心肌肌钙蛋白升高,这意味着心肌损伤可能是导致严重疾病和死亡的一种致病机制。因此,高肌钙蛋白水平与COVID-19患者的死亡率增加相关。本文简要回顾了COVID-19与心肌损伤的相关性。
  • 《纳米蛋白质组学能够对人血清中的低丰度蛋白进行蛋白分解分析》

    • 来源专题:纳米科技
    • 编译者:郭文姣
    • 发布时间:2020-09-07
    • 自然于2020年8月06日发布关于“纳米蛋白质组学能够对人血清中的低丰度蛋白进行蛋白分解分析”的文章,文章指出由上至下的质谱分析(MS)为基础的蛋白质组学提供了对蛋白质形态的全面分析,以实现对蛋白质功能的全蛋白理解。然而,由于血液蛋白质组的异常动态范围,MS检测血液中低丰度蛋白质仍然是一个未解决的挑战。在此,我们开发了一种集成的纳米蛋白质组学方法,将肽功能化超顺磁性纳米颗粒(NPs)与自上而下的质谱联用,用于直接从血清中富集和综合分析心肌肌钙蛋白I (cTnI),这是一种金标准的心脏生物标志物。这些NPs能够敏感性地富集cTnI (<1 ng/mL),具有高特异性和重复性,同时消耗高含量的蛋白,如人血清白蛋白(>1010比cTnI丰富)。我们证明了自顶向下的纳米蛋白质组学可以提供高分辨率的不同cTnI蛋白质形态的分子指纹图谱,以建立蛋白质形态的病理生理关系。这种可伸缩的、可重复的无抗体策略通常可以使直接从血清中提取的低丰度蛋白的蛋白分解分析能够揭示以前无法实现的分子细节。